Albuminuria‐lowering effect of dapagliflozin, exenatide, and their combination in patients with type 2 diabetes: A randomized cross‐over clinical studyAnnemarie B. van der Aart‐van der Beek, Hiddo J.L. Heerspink, C. David Sjöström et al.|Diabetes Obesity and Metabolism|2023Cited by 28
Author response for "Albuminuria lowering effect of dapagliflozin, exenatide and their combination in patients with type 2 diabetes: a randomized cross‐over clinical study"Annemarie B. van der Aart‐van der Beek, Hiddo JL Heerspink, Ellen M. Apperloo et al.|Unknown|2023Cited by 0